0
Letters |

5-α Reductase Inhibitors and Risk of Hip Fracture—Reply

Steven J. Jacobsen, MD, PhD; Jiaxiao M. Shi, PhD; Ronald K. Loo, MD
JAMA. 2009;301(9):935. doi:10.1001/jama.2009.183.
Text Size: A A A
Published online

Extract

In Reply: In response to Dr Bollu and colleagues, the duration of use of finasteride was highly correlated with total dose. The median (25th-75th percentile) time from first prescription to fracture/index date was 1.6 years (0.8-3.7 years) for case patients and 2.1 years (0.9-3.8 years) for control patients. When stratified by time since first prescription for finasteride (overall median), the inverse relationship with hip fracture was fairly consistent across categories of cumulative dose among men with more remote first prescriptions (odds ratio [OR], 0.61; 95% confidence interval [CI], 0.31-1.19; OR, 0.69; 95% CI, 0.37-1.26; and OR, 0.54; 95% CI, 0.25-1.15 for men with cumulative doses of 10-500 mg, 501-2750 mg, and ≥2751 mg, respectively). For men with more recent first prescriptions, the relationship was attenuated with larger cumulative doses (OR, 0.68; 95% CI, 0.38-1.22; OR, 1.17; 95% CI, 0.69-1.99; and OR, 1.66; 95% CI, 0.32-10.69 for men with cumulative doses of 10-500 mg, 501-2750 mg, and ≥2751 mg, respectively), but the estimates were unstable due to the small numbers of men with both large doses and recent prescriptions.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

March 4, 2009
Madhavi Bollu, MD; Andres C. Marte-Grau, MD; Ravi K. Bobba, MD
JAMA. 2009;301(9):935. doi:10.1001/jama.2009.182.
CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs